Save your place

Sign in to WhoBought

Please try again later.

OKYO Pharma Limited (OKYO) institutional ownership

Latest close $1.44 Jul 21, 2026
Market cap$117M 52-week range SectorHealthcare
Funds holding · Q2 2023
1
reported OKYO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q2 2023
Activity unavailable N/A
0 buyers · 1 sellers

OKYO Pharma Limited (OKYO) price and institutional activity

Dates

Q2 2023

$0 bought by 0 investors
$0 sold by 1 investors
Goldman Sachs Group Inc
Bought Sold Totals per quarter; hover a bar for the names.

OKYO Pharma Limited (OKYO) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Goldman Sachs Group Inc · Exited
Change −20K Δ Own −100.0% Date Q2 2023
Goldman Sachs Group Inc Exited· Q2 2023 −20K −100.0% Q2 2023
Data through Q2 2023 · filed Q2 2023
1 of 1

Famous investor activity in OKYO Pharma Limited (OKYO)

OKYO Pharma Limited (OKYO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Mantelli Flavio · Officer Grant (A) $28K
Price $1.40 Qty 20K Owned 20K Trade date Jul 21, 2026 Filed date Jul 22, 2026
Mantelli Flavio Officer Grant (A) $1.40 20K $28K 20K Jul 21, 2026 Jul 22, 2026
Cerrone Gabriele M. · Director Grant (A) $35K
Price $1.40 Qty 25K Owned 10.9M ΔOwn +0.2% Trade date Jul 20, 2026 Filed date Jul 21, 2026
Cerrone Gabriele M. Director Grant (A) $1.40 25K $35K 10.9M +0.2% Jul 20, 2026 Jul 21, 2026
Denoyer Bernard · Director Grant (A) $6K
Price $1.85 Qty 4K Owned 35K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Denoyer Bernard Director Grant (A) $1.85 4K $6K 35K Jun 8, 2026 Jun 10, 2026
Brancaccio John P. · Director Grant (A) $12K
Price $1.85 Qty 6K Owned 138K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Brancaccio John P. Director Grant (A) $1.85 6K $12K 138K Jun 8, 2026 Jun 10, 2026
Simon Willy Jules · Director Grant (A) $12K
Price $1.85 Qty 6K Owned 136K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Simon Willy Jules Director Grant (A) $1.85 6K $12K 136K Jun 8, 2026 Jun 10, 2026
Shah Keeren Rameshchandra · CFO Grant (A) $74K
Price $1.85 Qty 40K Owned 545K Trade date Jun 8, 2026 Filed date Jun 10, 2026
Shah Keeren Rameshchandra CFO Grant (A) $1.85 40K $74K 545K Jun 8, 2026 Jun 10, 2026
Cerrone Gabriele M. · Director Grant (A) $516K
Price $1.72 Qty 300K Owned 10.8M Trade date Jun 8, 2026 Filed date Jun 10, 2026
Cerrone Gabriele M. Director Grant (A) $1.72 300K $516K 10.8M Jun 8, 2026 Jun 10, 2026
7 of 7

OKYO Pharma Limited (OKYO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Chernett Jorey 3.8M
% of shares outstanding 9.5% Filing date Feb 13, 2026
Chernett Jorey 3.8M 9.5% Feb 13, 2026
Sirenia Capital Management LP 4.1M
% of shares outstanding 7.7% Filing date May 15, 2026
Sirenia Capital Management LP 4.1M 7.7% May 15, 2026
Woodline Partners LP 3.7M
% of shares outstanding 7.0% Filing date May 15, 2026
Woodline Partners LP 3.7M 7.0% May 15, 2026
Fonda Laura Natalia Monica 1.9M
% of shares outstanding 5.0% Filing date Oct 29, 2025
Fonda Laura Natalia Monica 1.9M 5.0% Oct 29, 2025
Dauntless Investment Group, LLC 472K
% of shares outstanding 1.2% Filing date Feb 12, 2026
Dauntless Investment Group, LLC 472K 1.2% Feb 12, 2026
Point72 Asset Management, L.P. 0
% of shares outstanding 0.0% Filing date May 15, 2026
Point72 Asset Management, L.P. 0 0.0% May 15, 2026
6 of 6

OKYO Pharma Limited (OKYO) ownership FAQ

Who owns OKYO?

1 reporting institutions disclosed OKYO position changes in the Q2 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q2 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.